Last updated: July 17, 2026

Application No. 18/718,484

BICYCLO [3.2.0] HEPTANE BIS(AMIDE) RXFP1 AGONISTS

Non-Final OA

Filed

Jun 11, 2024

Priority

Dec 15, 2021 — provisional 63/289,859 +1 more

Examiner

JEAN-LOUIS, SAMIRA JM

Art Unit

Tech Center

Assignee

Bristol-Myers Squibb Company

OA Round

1 (Non-Final)

This examiner grants 61% of cases after interview

— +45.1% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 975 resolved cases, 2023–2026

Examiner Intelligence

JEAN-LOUIS, SAMIRA JM View full profile →

Grants 61% of resolved cases

Career Allowance Rate

595 granted / 975 resolved

+1.0% vs TC avg

Strong +45% interview lift

Without

With

+45.1%

Interview Lift

resolved cases with interview

Typical timeline

2y 10m

Avg Prosecution

8 currently pending

Career history

989

Total Applications

across all art units

Statute-Specific Performance

§101

0.3%

-39.7% vs TC avg

§103

68.7%

+28.7% vs TC avg

§102

6.2%

-33.8% vs TC avg

§112

20.8%

-19.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 975 resolved cases

Prosecution Timeline

Jun 11, 2024

Application Filed

May 29, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/326,826

Patent 12173077

HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS

1y 6m to grant Granted Dec 24, 2024

17/922,797

Patent 11964962

SUBSTITUTED PYRIDAZINONE COMPOUND AND USE THEREOF

1y 5m to grant Granted Apr 23, 2024

18/008,636

Patent 11964983

SELECTIVE CDK4/6 INHIBITOR CANCER THERAPEUTICS

1y 4m to grant Granted Apr 23, 2024

18/239,348

Patent 11945811

NOVEL POTASSIUM CHANNEL INHIBITORS

7m to grant Granted Apr 02, 2024

18/098,505

Patent 11938217

READY-TO-USE INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING NEOSTIGMINE AND GLYCOPYRROLATE

1y 2m to grant Granted Mar 26, 2024

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

61%

Grant Probability

99%

With Interview (+45.1%)

2y 10m (~9m remaining)

Median Time to Grant

Low

PTA Risk

Based on 975 resolved cases by this examiner. Grant probability derived from career allowance rate.